Go Pro

Hong Kong Pharma Digital Technology (HKPD) Competitors

Hong Kong Pharma Digital Technology logo
$0.44 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$0.43 -0.01 (-1.96%)
As of 07/2/2026 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

HKPD vs. SCNX, TLIH, UUU, NHTC, and EDUC

Should you buy Hong Kong Pharma Digital Technology stock or one of its competitors? MarketBeat compares Hong Kong Pharma Digital Technology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Hong Kong Pharma Digital Technology include Scienture (SCNX), Ten-League International (TLIH), Universal Security Instruments (UUU), Natural Health Trends (NHTC), and Educational Development (EDUC). These companies are all part of the "wholesale" industry.

How does Hong Kong Pharma Digital Technology compare to Scienture?

Scienture (NASDAQ:SCNX) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap wholesale companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

Scienture has a beta of 3.28, meaning that its stock price is 228% more volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.49, meaning that its stock price is 149% more volatile than the broader market.

Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Scienture's return on equity.

Company Net Margins Return on Equity Return on Assets
ScientureN/A -56.28% -44.76%
Hong Kong Pharma Digital Technology N/A N/A N/A

Hong Kong Pharma Digital Technology has higher revenue and earnings than Scienture.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scienture$477.68K29.26-$41.51M-$2.51N/A
Hong Kong Pharma Digital Technology$20.31M0.24-$30KN/AN/A

Scienture currently has a consensus price target of $1.50, indicating a potential upside of 336.05%. Given Scienture's stronger consensus rating and higher possible upside, equities analysts clearly believe Scienture is more favorable than Hong Kong Pharma Digital Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scienture
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Scienture had 2 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 2 mentions for Scienture and 0 mentions for Hong Kong Pharma Digital Technology. Scienture's average media sentiment score of 0.63 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Scienture is being referred to more favorably in the media.

Company Overall Sentiment
Scienture Positive
Hong Kong Pharma Digital Technology Neutral

5.7% of Scienture shares are owned by institutional investors. 21.4% of Scienture shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Scienture beats Hong Kong Pharma Digital Technology on 9 of the 13 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Ten-League International?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Ten-League International (NASDAQ:TLIH) are both small-cap retail/wholesale companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Ten-League International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Company Net Margins Return on Equity Return on Assets
Hong Kong Pharma Digital TechnologyN/A N/A N/A
Ten-League International N/A N/A N/A

Ten-League International has higher revenue and earnings than Hong Kong Pharma Digital Technology.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hong Kong Pharma Digital Technology$20.31M0.24-$30KN/AN/A
Ten-League International$76.18M0.19$4.34MN/AN/A

In the previous week, Hong Kong Pharma Digital Technology's average media sentiment score of 0.00 equaled Ten-League International'saverage media sentiment score.

Company Overall Sentiment
Hong Kong Pharma Digital Technology Neutral
Ten-League International Neutral

Summary

Ten-League International beats Hong Kong Pharma Digital Technology on 2 of the 3 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Universal Security Instruments?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Universal Security Instruments (NYSE:UUU) are both small-cap wholesale companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Universal Security Instruments' net margin of -5.77%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Universal Security Instruments' return on equity.

Company Net Margins Return on Equity Return on Assets
Hong Kong Pharma Digital TechnologyN/A N/A N/A
Universal Security Instruments -5.77%-27.30%-12.88%

Hong Kong Pharma Digital Technology has higher revenue and earnings than Universal Security Instruments.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hong Kong Pharma Digital Technology$20.31M0.24-$30KN/AN/A
Universal Security Instruments$10.83M1.08-$400K-$1.04N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Universal Security Instruments
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Universal Security Instruments had 1 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 1 mentions for Universal Security Instruments and 0 mentions for Hong Kong Pharma Digital Technology. Universal Security Instruments' average media sentiment score of 0.76 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Universal Security Instruments is being referred to more favorably in the news media.

Company Overall Sentiment
Hong Kong Pharma Digital Technology Neutral
Universal Security Instruments Positive

Summary

Hong Kong Pharma Digital Technology beats Universal Security Instruments on 6 of the 9 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Natural Health Trends?

Natural Health Trends (NASDAQ:NHTC) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap wholesale companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

In the previous week, Natural Health Trends' average media sentiment score of 0.00 equaled Hong Kong Pharma Digital Technology'saverage media sentiment score.

Company Overall Sentiment
Natural Health Trends Neutral
Hong Kong Pharma Digital Technology Neutral

Natural Health Trends has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.49, meaning that its stock price is 149% more volatile than the broader market.

10.1% of Natural Health Trends shares are owned by institutional investors. 12.9% of Natural Health Trends shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natural Health Trends
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Natural Health Trends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natural Health Trends$38.25M0.41-$880K-$0.11N/A
Hong Kong Pharma Digital Technology$20.31M0.24-$30KN/AN/A

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Natural Health Trends' net margin of -3.03%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Natural Health Trends' return on equity.

Company Net Margins Return on Equity Return on Assets
Natural Health Trends-3.03% -4.88% -2.94%
Hong Kong Pharma Digital Technology N/A N/A N/A

Summary

Hong Kong Pharma Digital Technology beats Natural Health Trends on 5 of the 9 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Educational Development?

Educational Development (NASDAQ:EDUC) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap wholesale companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, valuation, risk and institutional ownership.

19.6% of Educational Development shares are owned by institutional investors. 11.9% of Educational Development shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Educational Development has a beta of 1.02, indicating that its share price is 2% more volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.49, indicating that its share price is 149% more volatile than the broader market.

Educational Development has a net margin of 10.15% compared to Hong Kong Pharma Digital Technology's net margin of 0.00%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Educational Development's return on equity.

Company Net Margins Return on Equity Return on Assets
Educational Development10.15% -17.66% -11.12%
Hong Kong Pharma Digital Technology N/A N/A N/A

Educational Development has higher revenue and earnings than Hong Kong Pharma Digital Technology.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Educational Development$22.91M0.57$2.33M$0.265.92
Hong Kong Pharma Digital Technology$20.31M0.24-$30KN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Educational Development
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Educational Development had 2 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 2 mentions for Educational Development and 0 mentions for Hong Kong Pharma Digital Technology. Educational Development's average media sentiment score of 0.55 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Educational Development is being referred to more favorably in the media.

Company Overall Sentiment
Educational Development Positive
Hong Kong Pharma Digital Technology Neutral

Summary

Educational Development beats Hong Kong Pharma Digital Technology on 8 of the 11 factors compared between the two stocks.

Get Hong Kong Pharma Digital Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for HKPD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HKPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HKPD vs. The Competition

MetricHong Kong Pharma Digital TechnologyWholesale – Drugs & Drug Proprietaries IndustryRetail SectorNASDAQ Exchange
Market Cap$4.84M$4.84M$27.07B$12.48B
Dividend YieldN/AN/A175.36%6.52%
P/E RatioN/AN/A21.3924.70
Price / Sales0.240.244.7199.49
Price / CashN/AN/A17.7657.09
Price / BookN/AN/A6.386.46
Net Income-$30K-$30K$960.18M$337.01M
7 Day Performance21.77%21.77%-0.10%1.69%
1 Month Performance-12.26%-12.26%17.19%3.81%
1 Year Performance-66.18%-66.18%-0.63%23.90%

Hong Kong Pharma Digital Technology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HKPD
Hong Kong Pharma Digital Technology
N/A$0.44
flat
N/A-66.2%$4.84M$20.31MN/A19
SCNX
Scienture
2.6572 of 5 stars
$0.36
-1.4%
$1.50
+316.4%
-76.0%$14.64M$430KN/AN/A
TLIH
Ten-League International
N/A$4.75
+3.3%
N/AN/A$13.97M$59.24MN/A64
UUU
Universal Security Instruments
N/A$4.57
+0.9%
N/A+15.2%$13.84M$10.83MN/A10
NHTC
Natural Health Trends
1.1976 of 5 stars
$1.55
-8.8%
N/A-60.3%$13.30M$39.78MN/A140

Related Companies and Tools


This page (NASDAQ:HKPD) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners